Sign in to view content

Systemic Biomarkers and Retinal Microvascular Alterations as Noninvasive Indicators of Diabetic Retinopathy and Nephropathy Severity and Diagnosis

Kasra Rezaei, M.D.

Video
Published 2025

Related

Advances in Diabetic Vitrectomy
Judy E. Kim, MD, FASRS
Updates from the Field
2016
Comparability of Diabetic Retinopathy Severity Evaluation on Gold Standard vs Ultra-Widefield Images in YOSEMITE/RHINE Phase 3 Studies
Barbara A. Blodi, MD
Annual Meeting Talks
2025
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Updates from the Field
2019

Category: Diabetic Retinopathy

See more